argenx SE (ARGX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ARGX SEC filings page.
argenx SE (ARGX) reported $4.2B in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
argenx converts reported profit into cash while operating with an unusually equity-funded, liquid balance sheet.
The key earnings-quality tension is that net income reached$1.3B , while free cash flow was$679M ; profit therefore did not translate one-for-one into cash. Because capital expenditures were only$6.2M , the gap is not explained by heavy reinvestment, making working-capital or other cash-timing effects important to interpretation.
Cash generation is meaningful but more restrained than accounting profit: free-cash-flow margin was
The balance sheet is lightly debt-funded and carries substantial short-term capacity: a current ratio of 5.2x and debt-to-equity of 0.0x accompany
Financial Health Signals
argenx SE does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, argenx SE generates $0.53 in operating cash flow ($685.2M OCF vs $1.3B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
argenx SE generated $4.2B in revenue in fiscal year 2025.
argenx SE reported $1.3B in net income in fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
argenx SE generated $679.0M in free cash flow in fiscal year 2025, representing cash available after capex.
argenx SE held $3.5B in cash against $36.3M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
argenx SE's net profit margin was 30.4% in fiscal year 2025, showing the share of revenue converted to profit.
argenx SE's ROE was 17.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
argenx SE invested $6.2M in capex in fiscal year 2025, funding long-term assets and infrastructure.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
ARGX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F |
|---|---|
| Revenue | $4.2B |
| Interest Expense | $3.2M |
| Income Tax | -$13.4M |
| Net Income | $1.3B |
| Diluted Shares (Avg) | 66M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted).
ARGX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F |
|---|---|
| Total Assets | $8.7B |
| Current Assets | $6.9B |
| Cash & Equivalents | $3.5B |
| Inventory | $473.5M |
| Accounts Receivable | $1.6B |
| Total Liabilities | $1.4B |
| Current Liabilities | $1.3B |
| Non-Current Liabilities | $39.4M |
| Long-Term Debt | $36.3M |
| Total Equity | $7.3B |
| Retained Earnings | -$279.8M |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.
ARGX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F |
|---|---|
| Operating Cash Flow | $685.2M |
| Capital Expenditures | $6.2M |
| Free Cash Flow | $679.0M |
| Investing Cash Flow | $984.0M |
| Financing Cash Flow | $233.0M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.
ARGX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F |
|---|---|
| Net Margin | 30.4% |
| Return on Equity | 17.6% |
| Return on Assets | 14.9% |
| Current Ratio | 5.23 |
| Debt-to-Equity | 0.01 |
| Asset Turnover | 0.49 |
| FCF Margin | 16.0% |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| argenx SE ARGX | FY2025 | $4.2B | $1.3B | 30.4% | $51.9B | — |
| Regeneron Pharmaceuticals Inc REGN | FY2025 | $14.3B | $4.5B | 31.4% | $76.9B | 78/100 |
| BeOne Medicines Ltd. ONC | FY2025 | $5.3B | $286.9M | 5.4% | $40.1B | 57/100 |
| Alnylam Pharmaceuticals, Inc. ALNY | FY2025 | $3.7B | $313.7M | 8.5% | $31.1B | 51/100 |
| Insmed, Inc. INSM | FY2025 | $606.4M | -$1.3B | N/A | $22.0B | 51/100 |
| Vertex Pharmaceuticals Inc VRTX | FY2025 | $12.0B | $4.0B | 32.9% | $129.3B | 74/100 |
Where argenx SE Ranks
Frequently Asked Questions
What is argenx SE's annual revenue?
argenx SE (ARGX) reported $4.2B in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is argenx SE profitable?
Yes, argenx SE (ARGX) reported a net income of $1.3B in fiscal year 2025, with a net profit margin of 30.4%.
How much debt does argenx SE have?
As of fiscal year 2025, argenx SE (ARGX) had $3.5B in cash and equivalents against $36.3M in long-term debt.
What is argenx SE's net profit margin?
argenx SE (ARGX) had a net profit margin of 30.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is argenx SE's return on equity (ROE)?
argenx SE (ARGX) has a return on equity of 17.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is argenx SE's free cash flow?
argenx SE (ARGX) generated $679.0M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is argenx SE's operating cash flow?
argenx SE (ARGX) generated $685.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are argenx SE's total assets?
argenx SE (ARGX) had $8.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are argenx SE's capital expenditures?
argenx SE (ARGX) invested $6.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is argenx SE's current ratio?
argenx SE (ARGX) had a current ratio of 5.23 as of fiscal year 2025, which is generally considered healthy.
What is argenx SE's debt-to-equity ratio?
argenx SE (ARGX) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is argenx SE's return on assets (ROA)?
argenx SE (ARGX) had a return on assets of 14.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is argenx SE's P/E ratio?
argenx SE (ARGX) trades at 40.2x earnings, its market capitalization divided by net income of $1.3B net income, FY2025. The market capitalization is $51.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is argenx SE's price-to-sales ratio?
argenx SE (ARGX) trades at 12.2x sales, its market capitalization divided by revenue of $4.2B revenue, FY2025. The market capitalization is $51.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Are argenx SE's earnings high quality?
argenx SE (ARGX) has an earnings quality ratio of 0.53x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.